325
Views
7
CrossRef citations to date
0
Altmetric
Review

Tramadol extended-release in the management of chronic pain

Pages 401-410 | Published online: 28 Dec 2022

References

  • [ACR] American College of RheumatologyRecommendations for the medical management of osteoarthritis of the hip and knee. 2000 updateArthritis Rheum20004319051511014340
  • [ACR] American College of RheumatologyPatient education: Osteoarthritis [online]2005 Accessed 26 June 2006. URL: http://www.rheumatology.org/public/factsheets/oa_new.asp?aud=pat
  • [APF] American Pain FoundationPain facts: An overview of American pain surveys [online]2002 Accessed 18 September 2006. URL: http://www.painfoundation.org/page.asp?file=Library/PainSurveys.htm
  • [APS] American Pain SocietyChronic pain in America – Road-blocks to relief [online]1996 Accessed 18 Semptember 2006. URL: http://www.painreliefnetwork.org/wp-content/uploads/PressPacket/APSRoad-blocksToRelief.pdf
  • BabulNNoveckRChipmanHEfficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the kneeJ Pain Symptom Management2004285971
  • CaldwellBAldingtonSWeatherallMRisk of cardiovascular events and celecoxib: a systematic review and meta-analysisJ R Soc Med2006991324016508052
  • [CDC] Centers for Disease Control and PreventionPrevalence of disabilities and associated health conditions among adults–United States, 1999MMWR Morb Mortal Wkly Rep200150120511393491
  • [CDC] Centers for Disease Control and PreventionPrevalence of self-reported arthritis or chronic joint symptoms among adults–United States, 2001MMWR Morb Mortal Wkly Rep2002519485012437034
  • ChernyNIPortenoyRKThe management of cancer painCA Cancer J Clin1994442633038076244
  • CiceroTJInciardiJAAdamsEHRates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994–2004Pharmacoepidemiol Drug Saf200514851915892169
  • CiceroTJInciardiJAMunozATrends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004J Pain200566627216202959
  • CohenJMMenefeeLADoghramjiKSleep in chronic pain: problems and treatmentsInt Rev Psych20001211526
  • DesmeulesJAPiguetVCollartLContribution of monoaminergic modulation to the analgesic effect of tramadolBr J Clinical Pharmacol1996417128824687
  • EisendrathSJPsychiatric aspects of chronic painNeurology199545suppl 9S26348538883
  • Garcia-QuetglasEAzanzaJRSadabaBPharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotypePharmacol Res2007551223017175164
  • GlajchenMChronic pain: treatment barriers and strategies for clinical practiceJ Am Board Fam Pract2001142111811355054
  • GoughACMilesJSSpurrNKIdentification of the primary gene defect at the cytochrome P450 CYP2D locusNature199034777361978251
  • HenniesHHFriderichsESchneiderJReceptor binding, analgesic and antitussive potency of tramadol and other selective opioidsArzneimittlforschung198838877802849950
  • HenniesHHFriderichsEWilsmannKEffect of the opioid analgesic tramadol on inactivation of norepinephrine and serotoninBiochem Pharmacol198231165457092957
  • Hopman-RockMKraaimaatFWBijlsmaJWQuality of life in elderly subjects with pain in the hip or kneeQual Life Res199766769062444
  • HudsonMRichardHPiloteLDifferences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based studyBMJ20053301370615947399
  • [JCAHO] Joint Commission on Accreditation of Healthcare OrganizationsPain: current understanding of assessment, management, and treatments [online]2001 Accessed 3 October 2006. URL: http://www.npcnow.org/resources/PDFs/painmonograph.pdf
  • KayserVBessonJMGuilbaudGEffects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphineEur J Pharmacol199119537452065712
  • KearneyPMBaigentCHallsHDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ20063321302816740558 LabordeJMPowersMJSatisfaction with life for patients undergoing hemodialysis and patients suffering from osteoarthritisRes Nurs Health1980319246901190
  • LeighTJHindmarchIBirdHAComparison of sleep in osteoarthritic patients and age and sex matched healthy controlsAnn Rheum Dis1988474023345103
  • MattiaCColuzziFTramadol. Focus on musculoskeletal and neuropathic painMinerva Anestesiol2005715658416163147
  • MattiaCVanderahTRaffaRBCharacterization of the unusual antinociceptive profile of tramadol in miceDrug Dev Res199331193243
  • MenefeeLACohenMJAndersonWRSleep disturbance and nonmalignant chronic pain: a comprehensive review of the literaturePain Med200011567215101904
  • MenefeeLAFrankEDDoghramjiKSelf-reported sleep quality and quality of life for individuals with chronic pain conditionsClin J Pain200016290711153783 PageJHenryDConsumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problemArch Intern Med20001607778410737277
  • ParrottTUsing opioid analgesics to manage chronic noncancer pain in primary careJ Am Board Fam Pract19991229330610477194
  • RaffaRBFriderichsEReimannWOpioid and nonopioid components independently contribute to the mechanism of action of tramadol, an‘atypical’opioid analgesicJ Pharmacol Exp Ther1992260275851309873
  • RaffaRBNayakRKLiaoSThe mechanism of action and pharmacokinetics of tramadol hydrochlorideRev Cont Pharmacol1995648598
  • SchnitzerTJKaminMOlsonWHTramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled studyArthritis Rheum1999421370710403264
  • StephensJLaskinBPashosCThe burden of acute postoperative pain and the potential role of the COX-2-specific inhibitorsRheumatology (Oxford)200342suppl 3iii405214585917
  • StewartWFRicciJACheeELost productive time and cost due to common pain conditions in the US workforceJAMA200329024435414612481
  • TurnerJADeyoRALoeserJDThe importance of placebo effects in pain treatment and researchJAMA19942711609147880221
  • UltramPIImmediate-release package insert2004Raritan, NJOrtho-McNeil Inc
  • UltramPIExtended-release package insert2006Raritan, NJOrtho-McNeil Inc
  • WeinsteinSMLauxLFThornbyJIPhysicians’ attitudes towards pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain InitiativeSouth Med J2000934798710832945
  • YelinECallahanLFfor National Arthritis Data Work GroupsThe economic cost and social and psychological impact of musculoskeletal conditionsArthritis Rheum1995381351627575685